Home Healthcare IT Artificial Organs Market Size, Trends and Growth Analysis Report | 2030

Artificial Organs Market

Artificial Organs Market Size, Share & Trends Analysis Report By Product (Artificial Organs, Kidney, Heart, Lungs, Liver, Pancreas, Artificial Bionics, Cochlear implant, Exoskeleton, Bionic limbs, Vision bionics, Brain bionics), By Technology (Mechanical bionics, Electronic bionics), By Type (Artificial Heart, Prosthetic heart valves, Ventricular assistance devices, Cardiac pacemakers, Material Type, Silicon, Plastics, Steel), By Organ Type (Permanent Artificial Organs, Temporary Artificial Organs) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI652DR
Study Period 2018-2030 CAGR 8.5%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD XX Billion
Forecast Year 2030 Forecast Year Market Size USD 23255 Million
Largest Market North America Fastest Growing Market Europe
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

Experience a healthcare revolution with the artificial organs market size projected to reach USD 23,255 million by 2030, boasting a robust CAGR of 8.5%. In 2018, 36,528 transplants were performed in the U.S., as per the Health Resources and Services Administration. The figure seems high until we look at the number of people yet awaiting a transplant; as of July 2019, 113,000 people awaited their turn for a transplant in the U.S. At least temporarily, the prospects of a global economic recovery from the COVID-19 epidemic were hampered by the Russia-Ukraine war. Due to the conflict between these two nations, numerous nations are now subject to economic sanctions, commodity prices have skyrocketed, and supply chain disruptions have resulted in the inflation of goods and services, impacting numerous global markets.

About 20 people lose their lives every day waiting for a transplant—lives that could be potentially saved by bridging the gap between the number of organs needed and those available. Artificial organs present the potential to save these lives, and the rising demand for organ transplants is the foremost factor providing impetus to the artificial organs market.

Accidents, health issues, and autoimmune diseases, among others, can lead to organ failure. Changing lifestyles and food patterns in the last two decades have also been exacerbating human health. While the need for organs is high, awareness associated with organ transplants remains low in many countries.

Table: Common Causes of Organ Failure


Market Dynamics

Artificial Organ Development through the Technological Marvel That Is 3D Bioprinting

The technological marvel of 3D bioprinting has made artificial organ production possible. The technology is constantly evolving to enhance the effectiveness of artificial organs. Developments and breakthroughs in 3D bioprinting are, thus, expected to drive the artificial organs market growth during the forecast period.

Apart from the main organs, scientists have been successful in creating the thyroid gland with the help of technological advancements in 3D bioprinting. Further developments in the creation of complicated artificial organs are in the R&D phase. Production of the thyroid gland, a patch of actually beating heart cells, and tibia replacement are some of 3D bioprinting's latest phenomenal achievements.

Microscopy and Mathematics: The Future of Artificial Organs

Researchers at Stanford have stood by mathematics and microscopy for establishing the future of artificial organs as they seek to discover mathematical rules underpinning brain growth. They chose to examine the brain of a planarian, a millimeter-long flatworm capable of growing its head back after amputation. Results concluded that neuronal patterning in the human brain could one day be successfully and effectively used in the tissue engineering field, which is closely related to the development of artificial organs.

Out of the box researches are expected to be game-changers in the global artificial organ market. More focus and further research could one day lead to the functional and neuronal mapping of the brain, which may help in creating a highly effective artificial organ with numerous possibilities, including slow aging, frequent organ replacements, and many others.

Regional Analysis

North America

North America dominates the artificial organs market. As per the "U.S. Department of Health and Human Services" Health Resources and Services Administration, one person is added to the waiting list for organs every ten minutes. The number of people awaiting organs rose from 23,198 in 1991 to 115,000 in 2017, marking a five-fold increase. The number of children under 18 on the waiting list rose to 2,000 in 2019.

In light of the growing organ waiting list, governments are taking initiatives to support the R&D of artificial organs, which is expected to augment North America's artificial organs market. Rising awareness regarding the benefits of artificial organs, including no resistance from the body and a short or no waiting time, is expected to bolster the regional growth momentum in years to come.


Europe is the epicenter of the rapidly evolving 3D printing technology. Last year alone, the region saw a plethora of advancements in 3D bioprinting. The high prevalence of Crohn's disease, polycystic kidney disease, and diabetes, among other diseases, in Europe is translating into a higher rate of organ failure, particularly in Germany and the U.K.

South America

The growth of medical tourism drives South America's artificial organ market. Additionally, industrial growth is attracting investments from healthcare companies in the form of manufacturing plants in South America. High alcohol consumption and the increasing prevalence of several diseases are expected to further oversee an upsurge in the demand for artificial organs.

The Middle East and Africa

The Middle East and Africa region is expected to account for the smallest global artificial organs market share. Organ transplant patients in the Middle East prefer to travel to Asian countries for better and cheaper medical services. And in Africa, the poor economic scenario prevents access to artificial organs.

Report Scope

Report Metric Details
By Product
  1. Artificial Organs
  2. Kidney
  3. Heart
  4. Lungs
  5. Liver
  6. Pancreas
  7. Artificial Bionics
  8. Cochlear implant
  9. Exoskeleton
  10. Bionic limbs
  11. Vision bionics
  12. Brain bionics
By Technology
  1. Mechanical bionics
  2. Electronic bionics
By Type
  1. Artificial Heart
  2. Prosthetic heart valves
  3. Ventricular assistance devices
  4. Cardiac pacemakers
  5. Material Type
  6. Silicon
  7. Plastics
  8. Steel
By Organ Type
  1. Permanent Artificial Organs
  2. Temporary Artificial Organs
Company Profiles B. Braun SE (Germany), Boston Scientific Corporation (U.S.), Getinge AB. (Sweden), ABIOMED. (U.S.), Asahi Kasei Corporation (Japan), Berlin Heart (Germany), CARMAT (France), Jarvik Heart, Inc. (U.S.), Terumo Corporation (Japan), SynCardia Systems, LLC (U.S.), Nipro Europe Group Companies (Japan), Medtronic (Ireland), Organovo Holdings Inc. (U.S.), NexImmune (U.S.), Diabeloop SA (France), Admetsys (U.S.), Defymed (France), Pancreum, Inc. (U.S.), Beta Bionics Inc. (U.S.), Integra LifeSciences (U.S.)
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The artificial organs market, for the purpose of our study, has been segmented on the basis of organ type.

  • Artificial Kidneys
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Heart
  • Artificial Lungs
  • Others

Artificial Kidneys Segment: High Incidence of Kidney Failure

The artificial kidneys segment accounted for a relatively high-value share in 2019. The prevalence of hepatitis B and C, diabetes, lupus, and UTIs that tend to damage the kidneys and long-term exposure to drugs such as NSAIDS contribute to the high incidence of kidney failure, which in turn accelerates the demand for artificial kidneys.

Artificial Liver Segment — Increasing Alcohol Consumption

The artificial liver segment is expected to grow significantly in years to come with the rising consumption of alcohol among teenagers and geriatrics. The liver is prone to fattiness in cases of heavy alcohol consumption for long durations. The last five years have seen a surge in the demand for artificial livers, which is largely attributable to changing lifestyles, predominantly among low- to middle-income families.

Artificial Lungs Segment: Prevalence of Smoking

The rising population of smokers has seen an upsurge in the number of respiratory failure cases. The rising prevalence of emphysema and chronic bronchitis on account of alarming pollution levels is translating to an increase in the need for artificial lung transplants in Bangladesh, Pakistan, India, Argentina, South Africa, and Dubai, among other countries.

The coronavirus pandemic and ever-increasing pollution levels are expected to see an increase in the demand for artificial lungs. The coronavirus pandemic is expected to particularly influence demand during 2021–2023 as the virus affects the respiratory system.

Market Size By Product

Top Key Players

B. Braun SE (Germany), Boston Scientific Corporation (U.S.), Getinge AB. (Sweden), ABIOMED. (U.S.), Asahi Kasei Corporation (Japan), Berlin Heart (Germany), CARMAT (France), Jarvik Heart, Inc. (U.S.), Terumo Corporation (Japan), SynCardia Systems, LLC (U.S.), Nipro Europe Group Companies (Japan), Medtronic (Ireland), Organovo Holdings Inc. (U.S.), NexImmune (U.S.), Diabeloop SA (France), Admetsys (U.S.), Defymed (France), Pancreum, Inc. (U.S.), Beta Bionics Inc. (U.S.), Integra LifeSciences (U.S.) Others

Frequently Asked Questions (FAQs)

What is the estimated growth rate (CAGR) of the Artificial Organs Market?
The market size is growing at a CAGR of 8.5% from 2022 to 2030.
North America has the largest share of this market.
Artificial organ development through the technological marvel that is 3D bioprinting is the key driver for the growth of this market.
The key players in this market are B. Braun SE (Germany),Boston Scientific Corporation (U.S.),Getinge AB. (Sweden),ABIOMED. (U.S.),Asahi Kasei Corporation (Japan), Berlin Heart (Germany),CARMAT (France),Jarvik Heart, Inc. (U.S.),Terumo Corporation (Japan),SynCardia Systems, LLC (U.S.).
The Projected value of this market is USD 23255 million by 2030.

We are featured on :